Search Results - "P. Viale"

Refine Results
  1. 1

    Advances in the therapy of bacterial bloodstream infections by Giannella, M., Bartoletti, M., Gatti, M., Viale, P.

    Published in Clinical microbiology and infection (01-02-2020)
    “…Advances in the diagnostic and therapeutic management of patients with bloodstream infections (BSIs) have been achieved in the last years, improving clinical…”
    Get full text
    Journal Article
  2. 2

    Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization by Gaibani, P., Re, M.C., Campoli, C., Viale, P.L., Ambretti, S.

    Published in Clinical microbiology and infection (01-04-2020)
    “…The aim of this study was to evaluate the incidence of ceftazidime/avibactam resistance among Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae…”
    Get full text
    Journal Article
  3. 3

    Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients by Marfella, R., Paolisso, P., Sardu, C., Bergamaschi, L., D’Angelo, E.C., Barbieri, M., Rizzo, M.R., Messina, V., Maggi, P., Coppola, N., Pizzi, C., Biffi, M., Viale, P., Galié, N., Paolisso, G.

    Published in Diabetes & metabolism (01-10-2020)
    “…Tocilizumab (TCZ) is used for treating moderate-to-severe Covid-19 pneumonia by targeting interleukin-6 receptors (IL-6Rs) and reducing cytokine release. Yet,…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Management of KPC-producing Klebsiella pneumoniae infections by Bassetti, M., Giacobbe, D.R., Giamarellou, H., Viscoli, C., Daikos, G.L., Dimopoulos, G., De Rosa, F.G., Giamarellos-Bourboulis, E.J., Rossolini, G.M., Righi, E., Karaiskos, I., Tumbarello, M., Nicolau, D.P., Viale, P.L., Poulakou, G.

    Published in Clinical microbiology and infection (01-02-2018)
    “…Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) has become one of the most important contemporary pathogens, especially in endemic…”
    Get full text
    Journal Article
  6. 6

    Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections by Russo, A., Concia, E., Cristini, F., De Rosa, F.G., Esposito, S., Menichetti, F., Petrosillo, N., Tumbarello, M., Venditti, M., Viale, P., Viscoli, C., Bassetti, M.

    Published in Clinical microbiology and infection (01-04-2016)
    “…In 2013 the US Food and Drug Administration (FDA) issued recommendations and guidance on developing drugs for treatment of skin infection using a new…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Treatment duration for Escherichia coli bloodstream infection and outcomes: retrospective single-centre study by Giannella, M., Pascale, R., Toschi, A., Ferraro, G., Graziano, E., Furii, F., Bartoletti, M., Tedeschi, S., Ambretti, S., Lewis, R.E., Viale, P.

    Published in Clinical microbiology and infection (01-10-2018)
    “…To investigate the impact of treatment duration on mortality and on relapse in patients with Escherichia coli bloodstream infection (BSI). Retrospective…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Antimicrobial therapy in critically ill patients : A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability by PEA, Federico, VIALE, Pierluigi, FURLANUT, Mario

    Published in Clinical pharmacokinetics (01-01-2005)
    “…Antimicrobials are among the most important and commonly prescribed drugs in the management of critically ill patients. Selecting the appropriate antimicrobial…”
    Get full text
    Journal Article
  16. 16

    Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections by Zaghi, I., Gaibani, P., Campoli, C., Bartoletti, M., Giannella, M., Ambretti, S., Viale, P., Lewis, R.E.

    Published in Clinical microbiology and infection (01-10-2020)
    “…Serum bactericidal titres (SBTs) were widely used in the 1970s and 1980s to monitor antimicrobial therapy but are now seldom recommended. It is the only…”
    Get full text
    Journal Article
  17. 17

    Exposure to psychotropic medications and COVID-19 course after hospital admission: Results from a prospective cohort study by D'Andrea, G., Pascale, R., Vatamanu, O., Giacomini, M.E., Caroccia, N., Giannella, M., Carloni, A.L., Cesa, F., Mordenti, O., Muratori, R., Tarricone, I., Viale, P.

    Published in Journal of psychosomatic research (01-04-2023)
    “…There is evidence of a bidirectional association between COVID-19 disease and psychiatric disorders. We aimed to assess whether exposure to psychotropic…”
    Get full text
    Journal Article
  18. 18

    Psychotropic drugs in patients with Covid-19: A retrospective cohort study (PsyCovid-19 study) by Mordenti, O., D'Andrea, G., Giannella, M., Carloni, A., Cesa, F., Muratori, R., Tarricone, I., Viale, P.

    Published in Journal of psychosomatic research (01-06-2022)
    “…Objective There is evidence of a bidirectional association between COVID-19 disease and psychiatric disorders. Our objective was to identify if individuals…”
    Get full text
    Journal Article
  19. 19

    Subtypes of depressive symptoms and inflammatory biomarkers: An exploratory study on a sample of HIV-positive patients by Norcini Pala, A, Steca, P, Bagrodia, R, Helpman, L, Colangeli, V, Viale, P, Wainberg, M.L

    Published in Brain, behavior, and immunity (01-08-2016)
    “…Highlights • Three sub-types of depressive symptoms were identified. • Somatic/cognitive-affective symptoms were associated with daily life impairment. •…”
    Get full text
    Journal Article
  20. 20